1. Home
  2. LILA vs BLFS Comparison

LILA vs BLFS Comparison

Compare LILA & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Latin America Ltd.

LILA

Liberty Latin America Ltd.

HOLD

Current Price

$8.88

Market Cap

1.6B

ML Signal

HOLD

Logo BioLife Solutions Inc.

BLFS

BioLife Solutions Inc.

HOLD

Current Price

$36.39

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LILA
BLFS
Founded
2017
1987
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
LILA
BLFS
Price
$8.88
$36.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$13.00
$32.00
AVG Volume (30 Days)
345.7K
826.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
7.55
77.27
EPS
N/A
0.94
Revenue
$4,442,200,000.00
$96,214,000.00
Revenue This Year
N/A
$19.73
Revenue Next Year
$7.23
$17.82
P/E Ratio
N/A
$37.18
Revenue Growth
N/A
16.97
52 Week Low
$4.77
$17.86
52 Week High
$9.04
$38.10

Technical Indicators

Market Signals
Indicator
LILA
BLFS
Relative Strength Index (RSI) 60.83 54.66
Support Level $7.15 $23.66
Resistance Level $9.04 $38.10
Average True Range (ATR) 0.19 0.90
MACD -0.00 -0.39
Stochastic Oscillator 98.20 31.00

Price Performance

Historical Comparison
LILA
BLFS

About LILA Liberty Latin America Ltd.

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: